
Overview
USANA fiscal Q2 net sales grow 11% yr/yr, beating analyst expectations, per LSEG data
Adjusted EPS for fiscal Q2 rises to $0.74, exceeding estimates, per LSEG data
Company reiterates fiscal year 2025 outlook, despite decline in active customers
Outlook
USANA reiterates fiscal 2025 net sales outlook of $920 mln to $1 bln
Company expects fiscal 2025 adjusted EPS of $2.35 to $3.00
USANA anticipates 8% to 17% sales growth in fiscal 2025
Hiya sales expected to grow 29% to 42% in fiscal 2025
Result Drivers
COMMERCIAL STRATEGY - USANA attributes 11% net sales growth to its comprehensive commercial strategy, including enhanced incentives and brand messaging
HIYA PARTNERSHIP - Hiya's strong quarter driven by new partnership with Disney, boosting sales and subscriber growth
CUSTOMER DECLINE - Active customer numbers fell across regions, impacting overall performance
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Sales | Beat | $235.85 mln | $225.20 mln (1 Analyst) |
Q2 Adjusted EPS | Beat | $0.74 | $0.54 (1 Analyst) |
Analyst Coverage
Wall Street's median 12-month price target for USANA Health Sciences Inc is $61.00, about 50.3% above its July 21 closing price of $30.29
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago
Press Release: ID:nBw7pmJNga